Basal insulin and glucagon-like peptide 1 receptor agonist (GLP1-RA) combination

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 3

Abstract

Diabetes mellitus is a chronic disease affecting more than 425 million people worldwide. Patients with type 2 diabetes frequently do not reach HbA1c targets. Historically insulin has been viewed as the most effective glucose-lowering agent in poorly controlled type 2 diabetes. When therapeutic intensification beyond basal insulin plus oral agents is required, adding a bolus, or prandial, rapidacting insulin analog has been recommended either in a stepwise approach or as a full basal-bolus inĀ¬sulin regimen. Adding a GLP-1 receptor agonist to basal insulin may be as effective as adding prandial insulin therapy. Two products, an insulin degludec/liraglutide combination (IDegLira) and an insulin glargine/lixisenatide combination (IGlarLixi), ARE approved for use in adults with T2DM. The efficacy and safety of these two basal insulin/GLP-1RA combination products have been studied in the DUAL program and Laxilan program. Clinical trial data has showed insulin/GLP-1RA fixed-ratio combinations are superior at reducing HbA1c with weight neutrality or weight loss rather than weight gain, as well as reduced hypoglycemia rates compared with basal insulin highlighting the great potential of these agents.

Authors and Affiliations

Sandeep Chaudhary, Khalid Shaikh

Keywords

Related Articles

Prevalence of refractive errors among carpet weavers of Kashmir valley, India

To determine the prevalence of refractive errors in carpet weaving population of Kashmir valley. In this cross sectional study, the sample was taken from various carpet weaving centres of Srinagar, carpet weaver was take...

Clinical profile of hyponatremia in tertiary care center in India : retrospective hospital based observational study

Hyponatremia is the most common electrolyte abnormality seen in clinical practice and is associated with altered sensorium, seizures, falls and cognitive dysfunction. Even mild hyponatremia could lead to severe complicat...

Glycemic variation in patients with diabetes fasting during Ramadan

This observational study was done to assess the glycaemic variations among people with diabetes who follow fasting during the month of Ramadan, and try and understand the reason behind these variations. For 52 patients,...

Efficacy and safety of fixed dose combination of drotaverine hydrochloride (80 mg) and mefenamic acid (250 mg) versus mefenamic acid (250mg) alone in treatment of primary dysmenorrhea : double-blind, randomised comparative study.

To compare the effect of combination of Mefenamic acid and Drotaverine hydrochloride with Mefenamic acid alone in primary dysmenorrhea. Out of 180 women with diagnosis of primary dysmenorrhea 87 women (Group A) were give...

Topical heparin for infusion associated superficial thrombophlebitis : A preventive approach

Maintaining a single indwelling intravenour (IV) catheter for a long duration is limited mainly due to the development of superficial thrombophlebitis. This, we decided to evaluate the efficacy and safety of heparin sodi...

Download PDF file
  • EP ID EP611948
  • DOI -
  • Views 196
  • Downloads 0

How To Cite

Sandeep Chaudhary, Khalid Shaikh (2018). Basal insulin and glucagon-like peptide 1 receptor agonist (GLP1-RA) combination. Journal of the Indian Medical Association, 116(3), 50-54. https://europub.co.uk/articles/-A-611948